Stocks Decline as Tariff Concerns Weigh on Market Sentiment

Stocks declined, with the S&P 500 down 0.40%, as renewed concerns over US-China trade relations, highlighted by Treasury Secretary Bessent's stalled talks and President Trump's accusations of tariff agreement violations, weighed on market sentiment. Despite supportive US economic data, including rising personal income and a cooling core PCE price index, the negative trade rhetoric overshadowed positive economic indicators. Marvell Technology led chip stocks lower after forecasting a Q2 adjusted gross margin slightly below consensus, while Ulta Beauty and Zscaler were among the gainers after reporting strong earnings and raising forecasts.

Analysis

US stock indexes are trading lower, with the S&P 500 down -0.40% and the Nasdaq 100 down -0.48%, primarily due to renewed concerns over US-China trade relations. These concerns were amplified by US Treasury Secretary Bessent's statement that trade talks were "a bit stalled" and President Trump's accusation that China violated a tariff agreement. This negative sentiment is overshadowing some supportive domestic economic data: April personal income rose a strong +0.8% m/m, the largest increase in 15 months, and the April core PCE price index, a key inflation gauge for the Federal Reserve, eased to +2.5% y/y, its slowest annual increase in over four years, suggesting a potentially dovish outlook for monetary policy. However, the US May Chicago PMI unexpectedly contracted, falling to 40.5. Comments from Dallas Fed President Logan indicated the Fed might maintain current interest rates for "quite some time," and markets are pricing in only a 2% probability of a rate cut at the June FOMC meeting. While Q1 S&P 500 earnings have been robust, with 77% of companies beating estimates and delivering +13.1% aggregate growth (versus +6.6% expected), the forecast for full-year 2025 S&P 500 corporate profit growth has been revised down to +9.4% from +12.5% in early January. Significant stock-specific movements include Marvell Technology (MRVL) declining over -6% on a weaker gross margin forecast, Regeneron Pharmaceuticals (REGN) falling over -17% due to disappointing drug trial results, and The Gap (GAP) plummeting over -19% after forecasting flat Q2 sales and warning of substantial tariff impacts. Conversely, Ulta Beauty (ULTA) surged over +14% and Zscaler (ZS) rose over +7% following strong earnings reports and upgraded forecasts.

Key Decisions for Investors

• Exercise caution as escalating US-China trade tensions are currently the primary market driver, potentially leading to increased volatility and overshadowing positive economic indicators.
• Closely monitor companies with significant exposure to international trade and tariffs, such as The Gap, given the direct warnings of earnings impacts if current tariff levels persist.
• Factor in the Federal Reserve's likely cautious stance on interest rates, with Dallas Fed President Logan suggesting a prolonged period of unchanged rates despite moderating PCE inflation, which could influence sector performance and valuation models.
• Focus on individual company fundamentals and earnings resilience, exemplified by the divergent stock reactions of companies like Ulta Beauty and Zscaler versus Marvell Technology and Regeneron Pharmaceuticals, to identify opportunities amid macroeconomic uncertainties and a downwardly revised full-year 2025 profit growth outlook for the S&P 500.